No headlines found.
ACCESS Newswire (Thu, 11-Dec 4:10 PM ET)
eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today
ACCESS Newswire (Thu, 13-Nov 4:30 PM ET)
ACCESS Newswire (Thu, 13-Nov 4:15 PM ET)
eXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM EST
ACCESS Newswire (Mon, 10-Nov 5:00 PM ET)
CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference
ACCESS Newswire (Thu, 30-Oct 4:10 PM ET)
CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference
ACCESS Newswire (Wed, 29-Oct 5:40 PM ET)
CEO of eXoZymes to Present at ThinkEquity's Annual Investor Conference
ACCESS Newswire (Thu, 23-Oct 4:50 PM ET)
Driving the Cell-Free Revolution: eXoZymes Leaders Join BioMADE Leadership & Technical Committees
ACCESS Newswire (Tue, 30-Sep 4:10 PM ET)
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.
Exozymes trades on the NASDAQ stock market under the symbol EXOZ.
As of December 19, 2025, EXOZ stock price climbed to $12.30 with 10,047 million shares trading.
EXOZ has a market cap of $103.16 million. This is considered a Micro Cap stock.
The top ETF exchange traded funds that EXOZ belongs to (by Net Assets): VXF, IWC.
EXOZ support price is $11.24 and resistance is $13.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EXOZ shares will trade within this expected range on the day.